Epigene Labs Revenue and Competitors
Estimated Revenue & Valuation
- Epigene Labs's estimated annual revenue is currently $5M per year.
- Epigene Labs's estimated revenue per employee is $155,000
Employee Data
- Epigene Labs has 32 Employees.
- Epigene Labs grew their employee count by 0% last year.
Epigene Labs's People
Name | Title | Email/Phone |
---|---|---|
1 | Chief Staff | Reveal Email/Phone |
Epigene Labs Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $12.6M | 81 | -5% | N/A | N/A |
#2 | $19.5M | 126 | -2% | N/A | N/A |
#3 | $36.3M | 234 | 22% | N/A | N/A |
#4 | $19.7M | 127 | -17% | N/A | N/A |
#5 | $14.3M | 92 | 0% | $179.5M | N/A |
#6 | $49.4M | 208 | -8% | €201.1M | N/A |
#7 | $44.5M | 287 | -3% | N/A | N/A |
#8 | $7.6M | 49 | N/A | N/A | N/A |
#9 | $6.4M | 41 | N/A | N/A | N/A |
#10 | $17.2M | 111 | -15% | N/A | N/A |
What Is Epigene Labs?
Over the past couple of decades, the exponential progress of sequencing technologies has allowed an increasing number of cancer patients to benefit from precision oncology. However, the aggregation, analysis, and visualization of the massive amounts of genomic data remain a major challenge for precision oncology expansion. The Epigene Labs technology platform enables cancer drug hunters to seamlessly leverage advanced artificial intelligence in transforming genomic data into actionable insights for designing precision oncology approaches. With R&D in Paris and business development in Boston, the company operates in the setting of value-based partnerships with world leading cancer centers and high-profile biotechs.
keywords:N/AN/A
Total Funding
32
Number of Employees
$5M
Revenue (est)
0%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $5.2M | 32 | 3% | N/A |
#2 | $3.6M | 32 | -14% | N/A |
#3 | $3.6M | 32 | 10% | N/A |
#4 | $3.3M | 32 | 0% | N/A |
#5 | $3.7M | 32 | 0% | N/A |